Canada - English - Health Canada

marcan pharmaceuticals inc - midodrine hydrochloride - tablet - 2.5mg - midodrine hydrochloride 2.5mg - alpha-adrenergic agonists

Canada - English - Health Canada

marcan pharmaceuticals inc - midodrine hydrochloride - tablet - 5mg - midodrine hydrochloride 5mg - alpha-adrenergic agonists

Canada - English - Health Canada

sanis health inc - midodrine hydrochloride - tablet - 2.5mg - midodrine hydrochloride 2.5mg

Canada - English - Health Canada

sanis health inc - midodrine hydrochloride - tablet - 5mg - midodrine hydrochloride 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - midodrine hydrochloride - oral tablet - 2.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - midodrine hydrochloride - oral tablet - 5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine ans is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine scp is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 2.5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine ans is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 2.5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine scp is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate.